{"clarifying_information": [{"clarifying_question1": "Are you most interested in how the choice between natural, synthetic, or semi-synthetic phage display libraries affects antibody diversity and success in therapeutic antibody discovery?", "clarifying_answer1": {"clarifying_answer": "Yes, my primary interest is understanding how the source of library diversity\u2014whether natural, synthetic, or semi-synthetic\u2014impacts the breadth and quality of antibody candidates discovered, especially with respect to their suitability and success for therapeutic antibody development."}}, {"clarifying_question2": "Would you like to focus specifically on technical design strategies for CDR regions (e.g., number diversified, loop lengths, amino acid composition) and how these influence the functional quality of antibody hits?", "clarifying_answer2": {"clarifying_answer": "Yes, I am interested in focusing specifically on the technical design strategies for CDR regions\u2014including how many CDRs are diversified, the selection of loop lengths, and amino acid composition\u2014and how these parameters influence the functional quality (such as affinity, specificity, developability) of antibody hits in phage display campaigns."}}, {"clarifying_question3": "Are you seeking detailed information on practical and technical factors (such as transformation efficiency, vector design, or amplification bias) that most limit library size or diversity in typical phage display workflows?", "clarifying_answer3": {"clarifying_answer": "Yes, I am interested in detailed information on the practical and technical factors\u2014such as transformation efficiency, vector design, and amplification bias\u2014that most limit library size or diversity in typical phage display workflows."}}], "better_queries_2": {"reformulated1": "How does the source of diversity\u2014natural (na\u00efve or immunized), synthetic, or semi-synthetic\u2014impact the breadth and developability of therapeutic antibody candidates discovered via phage display library screening?", "reformulated2": "In phage display library design, how do technical strategies for CDR diversification\u2014such as the number and types of CDRs diversified, loop length variation, and amino acid composition\u2014affect the binding affinity, specificity, and developability of antibodies isolated for therapeutic applications?", "reformulated3": "What are the key practical and technical bottlenecks, including bacterial transformation efficiency, phagemid vector design, and amplification bias, that currently limit the achievable size and functional diversity of phage display antibody libraries for effective antibody discovery?"}}
